1-3 of 3
Mary Redman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Third Generation CD20 Targeted CAR-T (MB-106) for Treatment of Relapsed/Refractory B-NHL and CLL

Mazyar Shadman, Cecilia Yeung, Mary Redman, Sang Yun Lee, Dong Hoon Lee, Susan Ra, Chaitra S. Ujjani, Bruce J. Dezube, Christina Poh, Edus H. Warren, Aude G. Chapuis, Damian J. Green, Andrew J. Cowan, Ryan D. Cassaday, Hans-Peter Kiem, Jordan Gauthier, Cameron J. Turtle, Ryan C. Lynch, Stephen D. Smith, Ajay K Gopal, David G. Maloney, Brian G. Till
Journal: Blood
Blood (2021) 138 (Supplement 1): 3872.
https://doi.org/10.1182/blood-2021-149181
Published: 2021
Journal Articles

CD20 Targeted CAR-T for High-Risk B-Cell Non-Hodgkin Lymphomas

Mazyar Shadman, MD, Ajay K. Gopal, MD, Stephen D. Smith, MD, Ryan C. Lynch, MD, Chaitra S. Ujjani, MD, Cameron J. Turtle, MBBS, PhD, Adam Greenbaum, MD PhD, Mary Redman, Cecilia Yeung, MD, Martina Sersch, MD PhD, Edus H. Warren, MD PhD, David G. Maloney, MD PhD, Brian G. Till, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3235.
https://doi.org/10.1182/blood-2019-125102
Published: 2019
Journal Articles

FDG PET-CT in follicular lymphoma: a case-based evidence review

Clinical Trials & Observations
Stephen D. Smith, Mary Redman, Kieron Dunleavy
Journal: Blood
Blood (2015) 125 (7): 1078–1082.
https://doi.org/10.1182/blood-2014-11-537522
Published: 2015